[HTML][HTML] Costs and healthcare utilisation of patients with heart failure in Spain

C Escobar, L Varela, B Palacios, M Capel… - BMC Health Services …, 2020 - Springer
Background Increasing the knowledge about heart failure (HF) costs and their determinants
is important to ascertain how HF management can be optimized, leading to a significant …

[HTML][HTML] Costs and healthcare utilisation of patients with chronic kidney disease in Spain

C Escobar, B Palacios, U Aranda, M Capel… - BMC Health Services …, 2021 - Springer
Background Data about the impact of chronic kidney disease (CKD) on health care costs in
Spain are scarce This study was aimed to evaluate cumulative costs and healthcare …

[HTML][HTML] Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain

C Escobar, U Aranda, B Palacios, M Capel, A Sicras… - nefrologia, 2021 - Elsevier
Objectives To describe the epidemiology, clinical profile, treatments, and to determine
cardiovascular and renal outcomes after two years of follow-up in a contemporary chronic kidneay …

The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very …

…, C Escobar, U Aranda, B Palacios, M Capel… - Clinical Kidney …, 2022 - academic.oup.com
Chronic kidney disease (CKD) is a common condition worldwide [1]; however, it is vastly
underdiagnosed as it frequently remains asymptomatic until reaching advanced stages [2]. Thus…

Real-life retrospective observational study to determine the prevalence and economic burden of severe asthma in Spain

A Sicras-Mainar, M Capel… - Journal of Medical …, 2020 - Taylor & Francis
Objective: We determined the percentage of patients with severe asthma and exacerbations
and evaluated the costs of the disease based on blood eosinophil counts. Methods: A …

[HTML][HTML] Primary vs. Secondary Heart Failure Diagnosis: differences in clinical outcomes, healthcare resource utilization and cost

…, G Moreno, N Rosillo, L Varela, M Capel… - Frontiers in …, 2022 - frontiersin.org
Background. There is scarce information on patients with secondary heart failure diagnosis (sHF).
We aimed to compare the characteristics, burden and outcomes of sHF with those with …

[HTML][HTML] Cost-effectiveness analysis of dapagliflozin for the treatment of type 2 diabetes mellitus in Spain: results of the DECLARE-TIMI 58 study

C Escobar, C Morales, M Capel, S Simón… - BMC Health Services …, 2022 - Springer
Background The objective of this study was to carry out a cost-effectiveness analysis of
dapagliflozin, as an add-on therapy to standard of care (SoC), for the treatment of type 2 diabetes …

Efficiency of naproxen/esomeprazole in association for osteoarthrosis treatment in Spain

M Capel, J Tornero, JL Zamorano, I Oyagüez… - … Clínica (English Edition), 2014 - Elsevier
Objective To assess, from the perspective of the National Healthcare System, the efficiency
of a fixed-dose combination of naproxen and esomeprazole (naproxen/esomeprazole) in the …

A comparison of budesonide/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain

…, E Calvo, M Muñoz, R Ampudia, M Capel - Journal of …, 2011 - Taylor & Francis
Objective. To study the effectiveness and safety in a real-life setting of budesonide/formoterol
(Symbicort) Maintenance And Reliever Therapy® (Symbicort SMART®), a simplified …

Cost-effectiveness of fixed-dose combinations therapies for chronic obstructive pulmonary disease treatment

M Capel, M Mareque, CJ Álvarez, L Lindner… - Clinical Drug …, 2018 - Springer
Background and Objective Chronic obstructive pulmonary disease (COPD), a progressive
lung disorder associated with decline of respiratory function, affects 10.2% of Spanish adults (…